Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) announced its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 12:45 p.m. Eastern Time.
The presentation will be available via a live webcast, with a replay accessible for two weeks after the event in the Event Archive on Inspire’s investor website: https://investors.inspiresleep.com.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, INSP declined 1.89%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peer moves are mixed, with names like ATEC and HAE showing gains and others like PRCT and LIVN declining, suggesting this conference update for INSP is more company-specific than part of a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 18 | Conference appearance | Neutral | -1.5% | Announcement of Piper Sandler healthcare conference presentation and webcast access. |
| Nov 03 | Earnings results | Positive | +2.3% | Q3 2025 results with revenue growth, high gross margin, and raised EPS guidance. |
| Oct 27 | Conference appearance | Neutral | +0.9% | UBS Global Healthcare Conference presentation and webcast details for investors. |
| Oct 10 | Clinical data update | Positive | -6.2% | Inspire V clinical data showing improved IPOP, shorter surgery, and AHI reductions. |
| Oct 06 | Earnings call timing | Neutral | -0.3% | Scheduling of Q3 2025 earnings release and conference call logistics. |
Earnings and major data updates have sometimes produced outsized moves, while routine conference presentations have generally coincided with modest price changes, occasionally negative.
Over the last few months, Inspire Medical Systems reported Q3 2025 revenue of $224.5M with reaffirmed 2025 guidance and share repurchases, which was followed by a modest positive price reaction. Clinical data for the Inspire V system released in October 2025 showed stronger efficacy and shorter surgical time yet coincided with a notable negative move. Multiple conference and presentation announcements, including UBS and Piper Sandler, produced relatively small price reactions. Today’s J.P. Morgan conference appearance continues this pattern of investor-relations outreach.
Market Pulse Summary
This announcement highlights Inspire Medical Systems’ plan to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 at 12:45 p.m. Eastern Time, with a live webcast and a replay available for two weeks. Investors may view this in the context of recent earnings, clinical data, and regulatory filings, focusing on any strategic updates or guidance commentary shared during the session and how they complement prior disclosures.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. Not financial advice.
MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026.
Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When will Inspire Medical Systems (INSP) present at the J.P. Morgan Healthcare Conference?
How can investors watch Inspire Medical Systems (INSP) present on January 12, 2026?
Will a replay of Inspire Medical Systems (INSP) presentation be available after January 12, 2026?
Where is the replay of the INSP J.P. Morgan presentation hosted?
What topics will Inspire (INSP) management cover at the J.P. Morgan conference?
Is the Inspire (INSP) J.P. Morgan webcast free to access for shareholders?
